Definitive Contract HHSN261201000066C

Ended Awarded Last action

Contract number
HHSN261201000066C
Awardee
Awarding agency
Obligated
$199,517

Award facts

Contract value 100% obligated
$199,517.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 11 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Baton Rouge, LA 70820, USA
Research
SBIR Program Phase I Action

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 2 $0
Other Administrative Action 1 · Deliverable modification $0
Original award $199,517

About this award

This is a Small Business Innovation Research (SBIR) Program Phase I contract awarded by the National Cancer Institute (NCI) to Biofluidica, Inc., a for-profit organization located in Baton Rouge, Louisiana. The contract has a ceiling value of $199,517.00 and is a Firm Fixed Price Definitive Contract. The contract was awarded on September 30, 2010 with an ultimate completion date of August 29, 2011. As an SBIR Phase I contract, this award supports early-stage research and development efforts.

Quick answers

Who was awarded contract HHSN261201000066C?

HHSN261201000066C was awarded to Biofluidica, Inc. by National Cancer Institute (National Institutes of Health) on September 30, 2010.

How much is contract HHSN261201000066C worth?

The government has obligated $199,517 on HHSN261201000066C.

Was contract HHSN261201000066C competed?

The extent of competition for HHSN261201000066C was full and open competition after exclusion of sources. The government received 11 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award